IL17A and psoriasis: Psoriasis is a hyperproliferative skin disease with a predominant Th1/Th17 response, with an upregulated concentration of multitude cytokines (TNF-α, IL-1β, IL-12, IL-17A, IL-22, IL-23, interferon-γ, and IL-13).